New insights into the in vitro susceptibility of Pythium insidiosum

Antimicrob Agents Chemother. 2014 Dec;58(12):7534-7. doi: 10.1128/AAC.02680-13. Epub 2014 Sep 15.

Abstract

We have determined the in vitro activity of several antibacterial and antifungal drugs against Pythium insidiosum using broth microdilution (BMD), disk diffusion, and Etest methods. The largest zones of inhibition (disk diffusion) and the lowest BMD and Etest MICs were observed for azithromycin, clarithromycin, linezolid, mupirocin, doxycycline, minocycline, and tigecycline. The in vitro activities observed suggest that antibacterials, which act by inhibiting protein synthesis, are promising candidate therapies for the treatment of pythiosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / pharmacology
  • Anti-Bacterial Agents / pharmacology*
  • Antifungal Agents / pharmacology*
  • Azithromycin / pharmacology
  • Clarithromycin / pharmacology
  • Doxycycline / pharmacology
  • Linezolid
  • Microbial Sensitivity Tests
  • Minocycline / analogs & derivatives
  • Minocycline / pharmacology
  • Mupirocin / pharmacology
  • Oxazolidinones / pharmacology
  • Pythium / drug effects*
  • Pythium / growth & development
  • Tigecycline

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Antifungal Agents
  • Oxazolidinones
  • Tigecycline
  • Azithromycin
  • Mupirocin
  • Minocycline
  • Clarithromycin
  • Linezolid
  • Doxycycline